Using paired isogenic MCF-7 breast cancer sublines with differing FGFR1 status, we demonstrated FGFR1-induced resistance to alpelisib and characterized molecular changes in the dysregulated crosstalk between RTK and ER pathways. This evidence concerns the gene FGFR1 and breast carcinoma.